Predictive factors of antiretroviral treatment <4 weeks among HIV-infected pregnant women in Cayenne, French Guiana

被引:4
|
作者
Elenga, Narcisse [1 ]
Hanf, Matthieu [2 ]
Nacher, Mathieu [3 ]
机构
[1] Ctr Hosp Cayenne Andree Rosemon, Serv Pediat, Cayenne, French Guiana
[2] Ctr Invest Clin Epedemiol Clin CIC EC Antilles Gu, Cayenne, French Guiana
[3] Coordinat Reg VIH COREVIH Guyane, Cayenne, French Guiana
关键词
human immunodeficiency virus infection; mother to child transmission; antiretroviral treatment < 4 weeks; French Guiana; TO-CHILD TRANSMISSION; RISK-FACTORS; DISEASE PROGRESSION;
D O I
10.1080/09540121.2011.592821
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
French Guiana is the French territory where the HIV epidemic is most preoccupying. In Cayenne, the mother to child HIV transmission rate was 6% in 2006-2008. Despite free testing and treatment, HIV pregnant women often have delayed or insufficient access to care. The aim of this study was to identify predictive factors of antiretroviral treatment <4 weeks in HIV pregnant women in Cayenne (French Guiana) and then to describe their attitudes, practices, and beliefs regarding HIV/AIDS. A case control study was conducted including all deliveries in Cayenne from 2003 to 2010. For each case, a standardized questionnaire including epidemiological, clinical, and biological data was administered. The analysis first described the summary statistics and then bivariate analysis studied the relation of each variable with the outcome. Multivariate analysis adjusted for the confounding factors. Thirty-three women in the first group and 96 in the control group were included in the study. Women born in French Guiana (OR = 5, IC95% = 1.22-20.86, p = 0.027) had a high risk of treatment <4 weeks. The other factors associated with treatment <4 weeks in our study were benefiting from food parcels (OR = 12.72, IC95% = 2.07-78.14, p = 0.006), consulting a traditional healer when sick (OR = 9.86, IC95% = 2.57-37.88, p = <0.001), and drug use (OR = 6.27, IC95% = 1.26-31.13, p = 0.025). These predictive factors should be considered in prevention programs against mother to child transmission of HIV.
引用
收藏
页码:46 / 53
页数:8
相关论文
共 50 条
  • [1] Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women
    Mellins, C. A.
    Chu, C.
    Malee, K.
    Allison, S.
    Smith, R.
    Harris, L.
    Higgins, A.
    Zorrilla, C.
    Landesman, S.
    Serchuck, L.
    LaRussa, P.
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2008, 20 (08): : 958 - 968
  • [2] Antiretroviral therapy for pregnant HIV-infected women
    Luber, AD
    Dong, BJ
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) : 509 - 509
  • [3] Pre- and postpartum antiretroviral choices among HIV-infected pregnant women
    Ejedepang-Koge, I
    Theall, K
    Clark, R
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (04) : 428 - 429
  • [4] Factors associated with antiretroviral adherence among HIV-infected women with children
    Murphy, DA
    Greenwell, L
    Hoffman, D
    [J]. WOMEN & HEALTH, 2002, 36 (01) : 97 - 111
  • [5] Antiretroviral Treatment Initiation Among HIV-Infected Pregnant Women with Low CD4+ Cell Counts in Gaborone, Botswana
    Chen, Jennifer Y.
    Ogwu, Anthony C.
    Svab, Petr
    Lockman, Shahin
    Moffat, Howard J.
    Gaolathe, Tendani
    Moilwa, Shana
    Stordal, Ketil
    Dryden-Peterson, Scott
    Moffat, Claire
    Makhema, Joseph
    Essex, M.
    Shapiro, Roger L.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 54 (01) : 102 - 106
  • [6] Risk factors for HIV-1 infection among pregnant women in French Guiana
    Cardoso, T
    Kazanji, M
    Magnan, F
    Denoyers, H
    Talarmin, A
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 15 (02): : 177 - 179
  • [7] Intensification of antiretroviral treatment with raltegravir for late-presenting HIV-infected pregnant women
    Thepnarong, N.
    Puthanakit, T.
    Chaithongwongwatthana, S.
    Anugulruengkitt, S.
    Anunsittichai, O.
    Theerawit, T.
    Pancharoen, C.
    Phanuphak, P.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20 : 59 - 59
  • [8] Perinatal risk factors for HIV-infected pregnant women
    Posokhova, S
    [J]. XIV INTERNATIONAL AIDS CONFERENCE: INTERVENTIONS AND PROGRAM IMPLEMENTATION, 2002, : 131 - 134
  • [9] Risk factors for tuberculosis among HIV-infected patients receiving antiretroviral treatment
    Lawn, SD
    Badri, M
    Wood, R
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (10) : 1348 - 1348
  • [10] Predictors of CD4 Eligibility for Antiretroviral Therapy Initiation Among HIV-Infected Pregnant Women in Lusaka, Zambia
    Liu, Katherine C.
    Mulindwa, Jessica
    Giganti, Mark J.
    Putta, Nande B.
    Chintu, Namwinga
    Chi, Benjamin H.
    Stringer, Jeffrey S. A.
    Stringer, Elizabeth M.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 57 (05) : E101 - E105